Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2015 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
Advancing Healthcare: From Testing to Treatment
By Patrick M. Schmidt
Features
Autoimmune Disease: A More Effective Treatment on the Horizon?
By
Elissa Ritt, MAS
Drawing on the Past and Looking to the Future: The Role of House Calls in the Age of Modern Medicine
By
Dana Henry
Treating PANDAS
By
Rodney P. Lusk, MD
Precision Medicine: A Seismic Shift in Treatment Strategy
By
Jim Trageser
The Future Has Arrived: A Wave of New Products Is Redefining Hemophilia Care
By
Keith Berman, MPH, MBA
The Perfect Storm for Patient-Focused Clinical Trials
By
Tina Tockarshewsky
BioTrends Watch
Washington Report
New Law to Prohibit Medigap from Covering Part B Deductible
Manufacturers Must Give Six-Month Notice for Stoppages
Third Track for Shared Savings ACOs Offers More Flexible Rules
Report Provides Stats for 2015 Health Insurance Marketplace Coverage
Reimbursement FAQs
ICD-10, Audits and Authorizations
Industry News
Gammaplex Approved for PI Patients 2 Years and Older
Wilate Approved for Perioperative Management of Bleeding in VWD Patients
FDA Grants 12-Year Exclusivity to Flublok
Stem Cell Treatment for MS Improves Immune System and Extends Remission
Stroke Drug May Halt Progression of Alzheimer's
Immune Checkpoint Inhibitors Promising in Melanoma
Shingles Vaccine Reduces Risk of Long-Term Pain in Patients
Personal Melanoma Vaccines Evoke Immune Response
AMA Adopts More Stringent Vaccine Requirement Policy
CMS Expands Coverage of HYQVIA for PI Patients to In-Home Use
Studies Find Interventions Increase HPV Vaccine Coverage
Recombinant IVIG Granted Orphan Drug Designation for CIDP
FDA Accepts BLA for CSL's rIX-FP for Hemophilia B Patients
Four States Introduce Legislation on Right to Try Experimental Drugs
Flu Vaccine May Protect Against Guillain-Barré Syndrome
Pertussis Vaccine Prevents Infant Mortality
Influenza Detection Test Receives FDA CLIA Waiver
Study Outlines Barriers to and Facilitators of Flu Vaccine Decisions
Octapharma USA Launches Co-Pay Program for Wilate
Baxalta Spins Off from Baxter BioScience
11 Companies Launch Biosimilars Forum
Influenza Often Overlooked with Bacterial Coinfection
GSK Ebola Shot Is Safe and Provokes an Immune Response
BioFocus
Industry Insight
More Is Better: High-Dose Flu Vaccine Helps Protect Seniors
By Keith Berman, MPH, MBA
Patient Profile
Infusing Hope: Living with Hemophilia
By Trudie Mitschang
BioSources
BioResearch
Plasma Exchange Effective in a Subset of Patients with Complex Regional Pain Syndrome
Pegylated Recombinant Factor VIII Appears Safe and Efficacious as Prophylactic and On-Demand Hemophilia A Therapy
Intravenous Immune Globulin Safe and Effective in Inflammatory Bowel Disease: Retrospective Study